ArticleClinical case reports2024

CDK4/6 and aromatase inhibitors as first-line treatment in metastatic high-grade neuroendocrine carcinoma of the breast: A case report.

Dionysia N Zouki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.